Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

142.85 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,405
Open 142.85
Bid (Size) 142.00 (1)
Ask (Size) 142.50 (1)
Prev. Close 142.85
Today's Range 142.85 - 142.85
52wk Range 115.61 - 497.49
Shares Outstanding 400,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
FDA Expert Panel Favors COVID-19 Boosters Targeting Omicron BA.4, BA.5 Subvariants
 
Via Benzinga
The FDA Just Handed BioNTech And Moderna A Gift — But Only One Jumped
The request is a boon for BioNTech and Moderna, both of which are facing a sales cliff. 
Via Investor's Business Daily

Performance

YTD
-39.23%
-39.23%
1 Month
-1.71%
-1.71%
3 Month
-17.07%
-17.07%
6 Month
-43.22%
-43.22%
1 Year
-39.21%
-39.21%

More News

Read More
Pfizer, Moderna Analysts Respond To FDA COVID Booster Ruling: 'Revenues Will Decline'
Via Benzinga
Novavax Stock Is in Prime Position For Speculation
Via InvestorPlace
FDA Eyes New Vaccine Composition In Response To COVID Mutations: Here's What You Need To Know
Via Benzinga
Moderna To establish New Vaccine Facility In Britain
Via Benzinga
Pfizer, Moderna, Novavax Tumble As FDA Experts Consider Omicron Shots
Via Investor's Business Daily
US Government Offers $75M Support For Lipid Systems Expansion Used In mRNA COVID-19 Vaccines
Via Benzinga
From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid
Via Investor's Business Daily
What Are Whales Doing With Moderna
Via Benzinga
Walmart And 3 Other Stocks Insiders Are Selling
Via Benzinga
7 Biotech Stocks With Key Catalysts Coming in July
Via InvestorPlace
Finally An Omicron-Blocking Shot? Sanofi, GSK Say Yes
Via Investor's Business Daily
Moderna Has Multi-Billion-Dollar Opportunity Outside Of COVID-19 Vaccines, Analyst Says
Via Benzinga
This Is What Whales Are Betting On Moderna
Via Benzinga
So What's Going On With Moderna Shares Rising Today?
Via Benzinga
Moderna's Bivalent COVID-19 Booster Shows Antibody Response Against Omicron Subvariants
Via Benzinga
Benzinga Before The Bell: Executive Shakeup At Amazon, Boeing Supply Chain Warning, Apple's Tim Cook Says 'Stay Tuned' On AR/MR And Other Top Financial Stories Wednesday, June 22
Via Benzinga
Moderna Announces Bivalent Booster mRNA-1273.214 Demonstrates Potent Neutralizing Antibody Response Against Omicron Subvariants BA.4 And BA.5
From Moderna, Inc.
Via AccessWire
Exposures COVID-19
Moderna Announces Plan to Bring mRNA Innovation to the United Kingdom
From Moderna, Inc.
Via AccessWire
Looking Into Moderna's Recent Short Interest
Via Benzinga
Looking At Moderna's Recent Whale Trades
Via Benzinga
Pfizer, Moderna Snag FDA OK For Covid Shots In Children At 6 Months Old
Via Investor's Business Daily
Moderna Receives FDA Authorization for Emergency Use of Its COVID-19 Vaccine for Children 6 Months of Age and Older
From Moderna, Inc.
Via AccessWire
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.